Spyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYRE and other ETFs, options, and stocks.About SYRE
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.
SYRE Key Statistics
Stock Snapshot
As of today, Spyre Therapeutics(SYRE) shares are valued at $80.10. The company's market cap stands at 7.39B, with a P/E ratio of -36.74.
During the trading session on 2026-10-16, Spyre Therapeutics(SYRE) shares reached a daily high of $80.88 and a low of $77.50. At a current price of $80.10, the stock is +3.4% higher than the low and still -1.0% under the high.
Trading activity shows a volume of 1.15M, compared to an average daily volume of 1.74M.
The stock's 52-week range extends from a low of $21.15 to a high of $110.18.
The stock's 52-week range extends from a low of $21.15 to a high of $110.18.
Analyst ratings
94%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.